2015 Conference Publication Effect of prasugrel versus clopidogrel in ACS patients with high or low BMI undergoing PCI: Results from the PROMETHEUS StudyChandrasekhar, Jaya, Baber, Usman, Sartori, Samantha, Aquino, Melissa, Strauss, Craig E., Muhlestein, Joseph B., Weiss, Sandra, Effron, Mark B., Keller, Stuart Y., Baker, Brian A., Chao, Jennifer, Rao, Sunil, Kapadia, Samir, Poddar, Kanhaiya L., DeFranco, Anthony, Kini, Annapoorna, Weintraub, William, Henry, Timothy D. and Mehran, Roxana (2015). Effect of prasugrel versus clopidogrel in ACS patients with high or low BMI undergoing PCI: Results from the PROMETHEUS Study. 27th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT), San Francisco Ca, Oct 11-15, 2015. NEW YORK: ELSEVIER SCIENCE INC. |
2015 Conference Publication Temporal Associations Between Myocardial Infarction, Major Bleeding and Mortality Risk in ACS Patients Undergoing PCI: Insights from the PROMETHEUS CohortBaber, Usman, Chao, Jennifer, Chandrasekhar, Jaya, Sartori, Samantha, Aquino, Melissa, Kini, Annapoorna, Rao, Sunil, Weintraub, William, Weiss, Sandra, Strauss, Craig E., Kapadia, Samir, Henry, Timothy D., DeFranco, Anthony, Muhlestein, Joseph B., Toma, Catalin, Pocock, Stuart J., Keller, Stuart Y., Effron, Mark B., Baker, Brian A. and Mehran, Roxana (2015). Temporal Associations Between Myocardial Infarction, Major Bleeding and Mortality Risk in ACS Patients Undergoing PCI: Insights from the PROMETHEUS Cohort. 27th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT), San Francisco Ca, Oct 11-15, 2015. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.jacc.2015.08.503 |
2015 Journal Article Contemporary use of platelet function and pharmacogenomic testingamongpatients with acute myocardial infarction undergoing percutaneous coronary intervention in the United StatesWang, Tracy Y., Henry, Timothy D., Mccoy, Lisa A., Berger, Peter B., Cohen, David J., Effron, Mark B., Zettler, Marjorie, Baker, Brian A., Messenger, John C. and Peterson, Eric D. (2015). Contemporary use of platelet function and pharmacogenomic testingamongpatients with acute myocardial infarction undergoing percutaneous coronary intervention in the United States. American Heart Journal, 170 (4), 706-714. doi: 10.1016/j.ahj.2015.06.021 |
2015 Journal Article One-year post-discharge resource utilization and treatment patterns of patients with acute coronary syndrome managed with percutaneous coronary intervention and treated with ticagrelor or prasugrelSimeone, Jason C., Molife, Cliff, Marrett, Elizabeth, Frech-Tamas, Feride, Effron, Mark B., Nordstrom, Beth L., Zhu, Yajun E., Keller, Stuart, Murphy, Brian R., Nair, Kavita V., Vetrovec, George W., Page, Robert L. and McCollam, Patrick L. (2015). One-year post-discharge resource utilization and treatment patterns of patients with acute coronary syndrome managed with percutaneous coronary intervention and treated with ticagrelor or prasugrel. American Journal of Cardiovascular Drugs, 15 (5), 337-350. doi: 10.1007/s40256-015-0147-y |
2015 Journal Article Association of discharge aspirin dose with outcomes after acute myocardial infarction: insights from the treatment with ADP receptor inhibitors: longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) studyXian, Ying, Wang, Tracy Y., McCoy, Lisa A., Effron, Mark B., Henry, Timothy D., Bach, Richard G., Zettler, Marjorie E., Baker, Brian A., Fonarow, Gregg C. and Peterson, Eric D. (2015). Association of discharge aspirin dose with outcomes after acute myocardial infarction: insights from the treatment with ADP receptor inhibitors: longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) study. Circulation, 132 (3), 174-181. doi: 10.1161/CIRCULATIONAHA.114.014992 |
2015 Journal Article Early medication nonadherence after acute myocardial infarction insights into actionable opportunities from the TReatment with ADP receptor iNhibitorS: longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) studyMathews, Robin, Peterson, Eric D., Honeycutt, Emily, Chin, Chee Tang, Effron, Mark B., Zettler, Marjorie, Fonarow, Gregg C., Henry, Timothy D. and Wang, Tracy Y. (2015). Early medication nonadherence after acute myocardial infarction insights into actionable opportunities from the TReatment with ADP receptor iNhibitorS: longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) study. Circulation-Cardiovascular Quality and Outcomes, 8 (4), 347-356. doi: 10.1161/CIRCOUTCOMES.114.001223 |
2015 Journal Article Cluster-randomized clinical trial examining the impact of platelet function testing on practice: The Treatment With Adenosine Diphosphate Receptor Inhibitors: longitudinal assessment of treatment patterns and events after acute coronary syndrome prospective open label antiplatelet therapy studyWang, Tracy Y., Henry, Timothy D., Effron, Mark B., Honeycutt, Emily, Hess, Connie N., Zettler, Marjorie E., Cohen, David J., Baker, Brian A., Berger, Peter B., Anstrom, Kevin J., Angiolillo, Dominick J. and Peterson, Eric D. (2015). Cluster-randomized clinical trial examining the impact of platelet function testing on practice: The Treatment With Adenosine Diphosphate Receptor Inhibitors: longitudinal assessment of treatment patterns and events after acute coronary syndrome prospective open label antiplatelet therapy study. Circulation-Cardiovascular Interventions, 8 (6). doi: 10.1161/CIRCINTERVENTIONS.114.001712 |
2015 Conference Publication IMPACT OF PROTON PUMP INHIBITOR USE ON THE COMPARATIVE SAFETY AND EFFECTIVENESS OF PRASUGREL VERSUS CLOPIDOGREL: INSIGHTS FROM TRANSLATE-ACSJackson, Larry R., Peterson, Eric, McCoy, Lisa, Ju, Christine, Zettler, Marjorie, Baker, Brian, Messenger, John, Faries, Douglas, Effron, Mark, Cohen, David and Wang, Tracy (2015). IMPACT OF PROTON PUMP INHIBITOR USE ON THE COMPARATIVE SAFETY AND EFFECTIVENESS OF PRASUGREL VERSUS CLOPIDOGREL: INSIGHTS FROM TRANSLATE-ACS. Scientific Session of the American-College-of-Cardiology (ACC), San Diego Ca, Mar 14-16, 2015. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/S0735-1097(15)60225-X |
2015 Conference Publication SELECTION OF PRASUGREL VERSUS CLOPIDOGREL AMONG MYOCARDIAL INFARCTION PATIENTS WITH HIGH VERSUS LOW PREDICTED MORTALITY AND BLEEDING RISKS: INSIGHTS FROM TRANSLATE-ACSVora, Amit, Peterson, Eric, McCoy, Lisa, Effron, Mark, Anstrom, Kevin, Faries, Douglas, Zettler, Marjorie, Fonarow, Gregg, Baker, Brian, Stone, Gregg and Wang, Tracy (2015). SELECTION OF PRASUGREL VERSUS CLOPIDOGREL AMONG MYOCARDIAL INFARCTION PATIENTS WITH HIGH VERSUS LOW PREDICTED MORTALITY AND BLEEDING RISKS: INSIGHTS FROM TRANSLATE-ACS. Scientific Session of the American-College-of-Cardiology (ACC), San Diego Ca, Mar 14-16, 2015. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/S0735-1097(15)60107-3 |
2014 Journal Article Real-world observations with prasugrel compared to clopidogrel in acute coronary syndrome patients treated with percutaneous coronary intervention in the United StatesBae, Jay P., Faries, Douglas E., Ernst, Frank R., Lipkin, Craig, Zhao, Zhenxiang, Moretz, Chad, Lieu, Hsiao D. and Effron, Mark B. (2014). Real-world observations with prasugrel compared to clopidogrel in acute coronary syndrome patients treated with percutaneous coronary intervention in the United States. Current Medical Research and Opinion, 30 (11), 2207-2216. doi: 10.1185/03007995.2014.941055 |
2014 Conference Publication Safety and Effectiveness of Prasugrel vs. Clopidogrel in the Setting of Bivalirudin vs. Heparin Use: 30-day Results from TRANSLATE-ACSHenry, Timothy D., Peterson, Eric, Cohen, David, Ju, Christine, Stone, Gregg W., Messenger, John C., Fonarow, Gregg C., Effron, Mark B., Baker, Brian A., Zettler, Marjorie and Wang, Tracy Y. (2014). Safety and Effectiveness of Prasugrel vs. Clopidogrel in the Setting of Bivalirudin vs. Heparin Use: 30-day Results from TRANSLATE-ACS. 26th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT), Washington Dc, Sep 13-17, 2014. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.jacc.2014.07.548 |
2014 Journal Article Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients High on-treatment platelet reactivity analysis of the TRIPLET trialDiodati, Jean G., Saucedo, Jorge F., Cardillo, Tracy E., Jakubowski, Joseph A., Henneges, Carsten, Effron, Mark B., Lipkin, Fred R., Walker, Joseph R., Duvvuru, Suman, Sundseth, Scott S., Fisher, Harold N. and Angiolillo, Dominick J. (2014). Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients High on-treatment platelet reactivity analysis of the TRIPLET trial. Thrombosis and Haemostasis, 112 (2), 311-322. doi: 10.1160/TH13-09-0747 |
2014 Journal Article Early post-discharge bleeding and antiplatelet therapy discontinuation among acute myocardial infarction patients treated with percutaneous coronary interventionWang, Tracy Y., Mccoy, Lisa, Henry, Timothy D., Effron, Mark B., Messenger, John C., Cohen, David J., Mark, Daniel B., Stone, Gregg W., Zettler, Marjorie, Singh, Mandeep, Fonarow, Gregg C. and Peterson, Eric D. (2014). Early post-discharge bleeding and antiplatelet therapy discontinuation among acute myocardial infarction patients treated with percutaneous coronary intervention. Journal of the American College of Cardiology, 63 (16), 1700-1702. doi: 10.1016/j.jacc.2013.12.012 |
2014 Journal Article Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Patients With Stable Coronary Artery Disease Results of the SWAP-2 Study (Switching Anti Platelet-2)Angiolillo, Dominick J., Curzen, Nicholas, Gurbel, Paul, Vaitkus, Paul, Lipkin, Fred, Li, Wei, Jakubowski, Joseph A., Zettler, Marjorie, Effron, Mark B. and Trenk, Dietmar (2014). Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Patients With Stable Coronary Artery Disease Results of the SWAP-2 Study (Switching Anti Platelet-2). Journal of the American College of Cardiology, 63 (15), 1500-1509. doi: 10.1016/j.jacc.2013.11.032 |
2014 Conference Publication DIFFERENTIAL USE BETWEEN PRASUGREL AND TICAGRELOR IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION IN ROUTINE PRACTICEEffron, Mark B., Molife, Cliff, Karkare, Swapna, Larmore, Cynthia, Zhu, Yajun, Lee, Won Chan, Frech-Tamas, Feride, Lieu, Hsiao and DeKoven, Mitch (2014). DIFFERENTIAL USE BETWEEN PRASUGREL AND TICAGRELOR IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION IN ROUTINE PRACTICE. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/S0735-1097(14)60225-4 |
2014 Conference Publication TRIPLE THERAPY AFTER ACUTE MYOCARDIAL INFARCTION: A COMPARISON OF CLOPIDOGREL VERSUS PRASUGREL FROM THE TRANSLATE-ACS STUDYJackson, Larry R., Zettler, Marjorie, Peterson, Eric, Ju, Christine, Effron, Mark, Messenger, John, Cohen, David, Stone, Gregg and Wang, Tracy (2014). TRIPLE THERAPY AFTER ACUTE MYOCARDIAL INFARCTION: A COMPARISON OF CLOPIDOGREL VERSUS PRASUGREL FROM THE TRANSLATE-ACS STUDY. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/S0735-1097(14)60026-7 |
2014 Conference Publication EFFICACY AND SAFETY OF PRETREATMENT AONG CONTEMPORARY ACUTE MYOCARDIAL INFARCTION PATIENTS TREATED WITH PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE TRANSLATE-ACS STUDYEffron, Mark B., Wang, Tracy, Fonarow, Gregg, Henry, Timothy, Zettler, Marjorie, Baker, Brian, McCoy, Lisa and Peterson, Eric (2014). EFFICACY AND SAFETY OF PRETREATMENT AONG CONTEMPORARY ACUTE MYOCARDIAL INFARCTION PATIENTS TREATED WITH PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE TRANSLATE-ACS STUDY. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/S0735-1097(14)60101-7 |
2013 Conference Publication A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Patients With Stable Coronary Artery Disease: Results of the SWAP-2 StudyAnaiolillo, Dominick J., Curzen, Nicholas, Gurbel, Paul A., Vaitkus, Paul, Lipkin, Fred, Li, Wei, Jakubowski, Joseph A., Zettler, Marjorie, Effron, Mark B. and Trenk, Dietmar (2013). A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Patients With Stable Coronary Artery Disease: Results of the SWAP-2 Study. Scientific Sessions and Resuscitation Science Symposium of the American-Heart-Association, Dallas Tx, Nov 16-17, 2013. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
2013 Conference Publication Comparative Effectiveness of Prasugrel vs. Clopidogrel Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: 30-Day Outcomes from the TRANSLATE-ACS Observational StudyWang, Tracy Y., Zettler, Marjorie, Effron, Mark B., McCoy, Lisa, Anstrom, Kevin, Fonarow, Gregg C., Messenger, John C., Stone, Gregg, Cohen, David, Henry, Timothy D. and Peterson, Eric (2013). Comparative Effectiveness of Prasugrel vs. Clopidogrel Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: 30-Day Outcomes from the TRANSLATE-ACS Observational Study. 25th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT), San Francisco Ca, Oct 27-Nov 01, 2013. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.jacc.2013.08.729 |
2013 Conference Publication High On-Treatment Platelet Reactivity among Contemporary Acute Myocardial Infarction Patients Treated with Percutaneous Coronary Intervention: Insights from the TRANSLATE-ACS StudyBagai, Akshay, Peterson, Eric, Honeycutt, Emily, Effron, Mark B., Stone, Gregg, Henry, Timothy D., Cohen, David, Anstrom, Kevin and Wang, Tracy Y. (2013). High On-Treatment Platelet Reactivity among Contemporary Acute Myocardial Infarction Patients Treated with Percutaneous Coronary Intervention: Insights from the TRANSLATE-ACS Study. 25th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT), San Francisco Ca, Oct 27-Nov 01, 2013. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.jacc.2013.08.882 |